NCT02266992View on ClinicalTrials.gov

Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Acquired Immune Deficiency Syndrome Virus
Interventions
BIOLOGICAL

Live attenuated Vaccine- Fluenz Tretra

Intra-nasal administration of 0.2ml (0.1ml in each nostril).

Trial Locations (1)

S10 2JF

Sheffield Teaching Hospitals NHS Foundation trust, Sheffield

All Listed Sponsors
lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT02266992 - Exploring Novel Mechanisms of Vaccine Failure LAIV Pilot Study | Biotech Hunter | Biotech Hunter